HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020

In response to increasing pretreatment drug resistance (PDR), Mexico changed its national antiretroviral treatment (ART) policy, recommending and procuring second-generation integrase strand-transfer inhibitor (INSTI)-based regimens as preferred first-line options since 2019. We present a four-year...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Morales, Claudia, Tapia-Trejo, Daniela, Matías-Florentino, Margarita, Quiroz-Morales, Verónica Sonia, Dávila-Conn, Vanessa, Beristain-Barreda, Ángeles, Cárdenas-Sandoval, Miroslava, Becerril-Rodríguez, Manuel, Iracheta-Hernández, Patricia, Macías-González, Israel, García-Mendiola, Rebecca, Guzmán-Carmona, Alejandro, Zarza-Sánchez, Eduardo, Cruz, Raúl Adrián, González-Rodríguez, Andrea, Reyes-Terán, Gustavo, Ávila-Ríos, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708254/
https://www.ncbi.nlm.nih.gov/pubmed/34959542
http://dx.doi.org/10.3390/pathogens10121587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708254/
https://www.ncbi.nlm.nih.gov/pubmed/34959542
http://dx.doi.org/10.3390/pathogens10121587

Ejemplares similares